MAYINGLONG HEMORRHOIDS- zinc oxide suppository 
Mayinglong Pharmaceutical Group Co., Ltd

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Mayinglong Hemorrhoids

Active Ingredients

Zinc Oxide   57.2%

Purpose

Zinc Oxide      Astrigent

Uses

To reduce fever and toxic materials, subduces swelling, and relieve from pain. To stop bleeding and promote tissue regeneration. For internal and external hemorrhoids.

Warning

Not for oral use.

Immerse it into cool water if it has softened during high temperature.

Eat more vegetables and fruits, avoid constipation, restrict cigarettes, wine and spicy foods.

Warning

Keep out of reach of children.

Warning

Apply it carefully during pregancy or as directed by a physician.

Directions

Insert one suppository into anus, twice a day or as directed by a physician.

Storage

Store tightly closed in a cool place.

Inactive Ingredients

Musk Ketone, Hyriopsis Cumingii Whole, Borneol, Panax Rotoginseng Root, Belladonna Leaf, Rhus Chinensis Whole, Diacetyltartaric and Fatty Acid Esters of Glycerol

Drug Facts

image description

MAYINGLONG HEMORRHOIDS 
zinc oxide suppository
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68511-350
Route of AdministrationRECTAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE1.7 g
Inactive Ingredients
Ingredient NameStrength
MUSK KETONE (UNII: 483V3E1L6J)  
HYRIOPSIS CUMINGII WHOLE (UNII: 8VRP283387)  
BORNEOL (UNII: M89NIB437X)  
PANAX NOTOGINSENG ROOT (UNII: GQX1C1175U)  
BELLADONNA LEAF (UNII: 6GZW20TIOI)  
RHUS CHINENSIS WHOLE (UNII: J6BED8187F)  
DIACETYLTARTARIC AND FATTY ACID ESTERS OF GLYCEROL (UNII: 248HN3Z28U)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:68511-350-866 in 1 BOX
1NDC:68511-350-821 in 1 BLISTER PACK
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34607/15/2009
Labeler - Mayinglong Pharmaceutical Group Co., Ltd (526823828)
Registrant - Mayinglong Pharmaceutical Group Co., Ltd (526823828)
Establishment
NameAddressID/FEIBusiness Operations
Mayinglong Pharmaceutical Group Co., Ltd526823828manufacture(68511-350)

Revised: 5/2014
Document Id: 0588618d-ba35-4588-a6f6-bba696427df2
Set id: 29ca2b59-b419-4904-a183-3ae93e0ee9ca
Version: 3055
Effective Time: 20140523
 
Mayinglong Pharmaceutical Group Co., Ltd